{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:12:39Z","timestamp":1788415959407,"version":"build-2803163510"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017700","name":"Henan Provincial Science and Technology Research Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Leptomeningeal metastasis (LM) is a serious complication of lung adenocarcinoma (LUAD). Owing to the difficulty in early diagnosis and the limited clinical benefit of available treatments, affected patients experience extremely poor outcomes. Thus, the machine-learning-enhanced predictive framework Prompt was developed to optimise early clinical identification and prognostic assessment. This model was designed to determine major risk factors for LM in patients with LUAD, estimate the possibility of LM onset and predict survival, thereby supporting clinical decision-making via an early-warning system and accurate survival prediction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data of patients diagnosed with LUAD complicated by LM (LUAD-LM) between 1 January 2012 and 1 January 2025 were obtained from electronic medical databases across multiple medical centres. Embedded feature selection was conducted using tree-based feature importance ranking. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC) to determine the most suitable machine-learning model. Shapley additive explanation (SHAP) values were applied to interpret the high-risk diagnostic model, and survival outcomes were examined using Cox proportional hazards regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 6,784 screened LUAD cases, 181 individuals met the inclusion criteria for patients with confirmed LUAD-LM. A high-risk diagnostic model for LUAD-LM was developed using the Tabular Prior-data Fitted Network (TabPFN), an approach recently published in\n                      <jats:italic>Nature<\/jats:italic>\n                      . In the test cohort, the model achieved an AUC of 0.842, with an accuracy of 0.880, a precision of 0.900, a recall of 0.947 and an F1 score of 0.923, reflecting consistently strong discriminatory ability. SHAP value analysis revealed that total CO\n                      <jats:sub>2<\/jats:sub>\n                      on arterial blood gas, TTLS, indirect bilirubin, EGFR exon 21 L858R mutation status, Karnofsky Performance Status (KPS) score and serum Ca\n                      <jats:sup>2+<\/jats:sup>\n                      levels were key contributors to LUAD-LM. For prognostic assessment, KPS score, serum Na\n                      <jats:sup>+<\/jats:sup>\n                      levels and serum Cl\n                      <jats:sup>-<\/jats:sup>\n                      concentrations were crucial determinants. A web-based calculator built on the Streamlit framework facilitated clinical application.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prompt framework delivers exploratory LM risk and survival estimations for Chinese patients with LUAD, serving as a preliminary risk-stratification reference rather than a universally applicable clinical diagnostic tool pending prospective external validation across diverse populations and healthcare systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1894987","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:15:09Z","timestamp":1788412509000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Interpretable machine learning for prediction of leptomeningeal metastasis in lung adenocarcinoma: a multi-centre retrospective study via \u201cPrompt\u201d model"],"prefix":"10.3389","volume":"16","author":[{"given":"Xinyang","family":"Li","sequence":"first","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxiang","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tianjin Medical University Cancer Institute & Hospital","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Fan","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingda","family":"Xie","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wei","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Yao","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renke","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of General Practice, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine","place":["Hangzhou, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital","place":["Zhengzhou, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Sun","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Qiu","sequence":"additional","affiliation":[{"name":"College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachun","family":"Sun","sequence":"additional","affiliation":[{"name":"Henan Key Laboratory of Cancer Epigenetics, Cancer Institute, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology","place":["Luoyang, Henan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1158\/1078-0432.Ccr-22-1585","article-title":"Leptomeningeal metastasis from non-small cell lung cancer and current landscape of treatments","volume":"29","author":"Ozcan","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181dc1a69","article-title":"Leptomeningeal metastases in the mri era","volume":"74","author":"Clarke","year":"2010","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00278","article-title":"Management of leptomeningeal metastases in non-oncogene addicted non-small cell lung cancer","volume":"8","author":"Turkaj","year":"2018","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.01.007","article-title":"Clinical utility of cerebrospinal fluid cell-free DNA as liquid biopsy for leptomeningeal metastases in alk-rearranged nsclc","volume":"14","author":"Zheng","year":"2019","journal-title":"J Thorac Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.06.029","article-title":"Leptomeningeal metastases in patients with nsclc with egfr mutations","volume":"11","author":"Li","year":"2016","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11060-013-1199-y","article-title":"Impact of egfr tyrosine kinase inhibitors versus chemotherapy on the development of leptomeningeal metastasis in never smokers with advanced adenocarcinoma of the lung","volume":"115","author":"Lee","year":"2013","journal-title":"J Neuro-Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s2213-2600(24)00428-4","article-title":"Estimated worldwide variation and trends in incidence of lung cancer by histological subtype in 2022 and over time: A population-based study","volume":"13","author":"Luo","year":"2025","journal-title":"Lancet Respir Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/jto.0000000000000669","article-title":"Epidermal growth factor receptor tyrosine kinase inhibitors for non-small-cell lung cancer patients with leptomeningeal carcinomatosis","volume":"10","author":"Liao","year":"2015","journal-title":"J Thorac Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000413661.58045.e7","article-title":"Leptomeningeal metastasis from systemic cancer","volume":"18","author":"Clarke","year":"2012","journal-title":"Continuum (Minneap Minn)"},{"key":"B10","article-title":"Mr imaging of leptomeningeal metastases: Comparison of three sequences","volume":"23","author":"Singh","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2016.12.006","article-title":"Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era","volume":"53","author":"Remon","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03190-3","article-title":"Association of mri findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer","volume":"143","author":"Ko","year":"2019","journal-title":"J Neuro-Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(10)70034-6","article-title":"Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours","volume":"11","author":"Beauchesne","year":"2010","journal-title":"Lancet Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.idnow.2025.105090","article-title":"Evaluating the impact of artificial intelligence in antimicrobial stewardship: A comparative meta-analysis with traditional risk scoring systems","volume":"55","author":"Pinto","year":"2025","journal-title":"Infect Dis Now"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-08328-6","article-title":"Accurate predictions on small data with a tabular foundation model","volume":"637","author":"Hollmann","year":"2025","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g7594","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (tripod): The tripod statement","volume":"350","author":"Collins","year":"2015","journal-title":"Bmj"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2012.03.002","article-title":"Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: Okayama lung cancer study group","volume":"77","author":"Umemura","year":"2012","journal-title":"Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.71463","article-title":"Cancer risk prediction using machine learning for supporting early cancer diagnosis in symptomatic patients: A systematic review of model types","volume":"14","author":"Pennisi","year":"2025","journal-title":"Cancer Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"22372","DOI":"10.1038\/s41598-022-26131-z","article-title":"Brain parenchymal and leptomeningeal metastasis in non-small cell lung cancer","volume":"12","author":"Li","year":"2022","journal-title":"Sci Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7206","article-title":"Development and validation of a nomogram to predict leptomeningeal metastases in lung adenocarcinoma: Cervical lymph node metastasis is an important association factor","volume":"13","author":"Hua","year":"2024","journal-title":"Cancer Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.03.015","article-title":"A molecular graded prognostic assessment (molgpa) model specific for estimating survival in lung cancer patients with leptomeningeal metastases","volume":"131","author":"Yin","year":"2019","journal-title":"Lung Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.S347323","article-title":"Systematic immunological level determined the prognosis of leptomeningeal metastasis in lung cancer","volume":"14","author":"Hong","year":"2022","journal-title":"Cancer Manag Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.lungcan.2022.09.013","article-title":"Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment","volume":"174","author":"Wang","year":"2022","journal-title":"Lung Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12416","article-title":"Tumor microenvironment signaling and therapeutics in cancer progression","volume":"43","author":"Goenka","year":"2023","journal-title":"Cancer Commun (Lond)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00320-2","article-title":"The metabolism of cancer cells during metastasis","volume":"21","author":"Bergers","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2021.10.014","article-title":"The crosstalk between pattern-recognition receptor signaling and calcium signaling","volume":"192","author":"Kong","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcb.2022.07.004","article-title":"Calcium homeostasis and cancer: Insights from endoplasmic reticulum-centered organelle communications","volume":"33","author":"Zheng","year":"2023","journal-title":"Trends Cell Biol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202409310","article-title":"Calcium channel blocker lacidipine promotes antitumor immunity by reprogramming tryptophan metabolism","volume":"12","author":"Sheng","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(17)30689-7","article-title":"Leptomeningeal metastases in non-small-cell lung cancer","volume":"19","author":"Cheng","year":"2018","journal-title":"Lancet Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3892\/ol.2024.14855","article-title":"Patients with non-small cell lung cancer with the exon 21 l858r mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (review)","volume":"29","author":"Liu","year":"2025","journal-title":"Oncol Lett"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/srep13574","article-title":"Egfr-l858r mutant enhances lung adenocarcinoma cell invasive ability and promotes Malignant pleural effusion formation through activation of the cxcl12-cxcr4 pathway","volume":"5","author":"Tsai","year":"2015","journal-title":"Sci Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2023.01.441","article-title":"Spurious electrolyte and acid-base disorders in the patient with cancer: A review","volume":"82","author":"Chowdhury","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.bulcan.2023.04.014","article-title":"Electrolyte disorders in oncological patients","volume":"111","author":"Saillant","year":"2024","journal-title":"Bull Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/mnh.0000000000000819","article-title":"Electrolytes disturbances in cancer patients","volume":"31","author":"Turcotte","year":"2022","journal-title":"Curr Opin Nephrol Hypertens"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1894987\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:15:11Z","timestamp":1788412511000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1894987\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":34,"alternative-id":["10.3389\/fonc.2026.1894987"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1894987","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1894987"}}